IDO1 and exocrine pancreatic carcinoma: Normally, it is expressed at a low level.29 Reportedly, overexpression of IDO has been confirmed in the lymphatic drainage areas of many malignant cancers, such as stomach carcinomas,30 breast neoplasms,22 lung tumors,31 pancreatic carcinomas, and colorectal tumors,32 among others.